Phase III Comparative Study of Vinorelbine Combined With Doxorubicin Versus Doxorubicin Alone in Disseminated Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Regression Models and Life-Tables

1972 • 27,145 citations

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 • 14,121 citations

Assessment of Quality-of-Life Outcomes

1996 • 2,499 citations

Assessment of response to therapy in advanced breast cancer

1977 • 705 citations

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer

1999 • 639 citations

Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland

1977 • 633 citations

Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.

1996 • 426 citations

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.

1993 • 333 citations

Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group.

1992 • 321 citations

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.

1989 • 246 citations

Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens

1993 • 200 citations

Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer.

1995 • 198 citations

Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer.

1995 • 196 citations

Interrupted versus Continuous Chemotherapy in Patients with Metastatic Breast Cancer

1991 • 192 citations

Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.

1994 • 164 citations

Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial.

1998 • 149 citations

Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.

1995 • 147 citations

A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma

1987 • 116 citations

A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.

1988 • 110 citations

Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer.

1994 • 102 citations

Randomized Trial of Doxorubicin, Bisantrene, and Miltoxantrone in Advanced Breast Cancer: A Southwest Oncology Group Study

1991 • 73 citations

The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug.

1987 • 64 citations

Doxorubicin in advanced breast cancer: Influence of schedule on response, survival and quality of life

1992 • 62 citations

Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer.

1974 • 62 citations

A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma

1999 • 54 citations

Combined doxorubicin/vinorelbine (Navelbine) therapy in the treatment of advanced breast cancer.

1995 • 23 citations

Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposure

1985 • 14 citations

Deleted Work

1955 • 0 citations